Lowenstein represented Osmosis in the transaction, while Cravath represented RELX. Elsevier, a global leader in research publishing and information analytics, executed the acquisition of digital health...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here